ArticleEuropean journal of haematology2026

Cost-Effectiveness of Venetoclax-Based Treatment in Treatment-Naïve Fit Patients With CLL Without TP53 Aberrations.

Lars Holger Ehlers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.